REDUCING CAPITAL PROJECT COST, SCHEDULE, AND RISK
The WuXi Biologics Dundalk, Ireland facility is setting new industry benchmarks in flexibility, cost of goods and time to market for a large-scale biopharmaceutical manufacturing plant.
ABEC delivered a fully integrated single-use / stainless steel hybrid bioprocess solution in 26 months from start of concept through turnover at site.
“We are very happy we found a partner who can support us on both WuXi Biologics Speed and WuXi Biologics Quality.”
Chris Chen, CEO, WuXi Biologics